Inhibition of the Raf–MEK1/2–ERK1/2 Signaling Pathway, Bcl-xLDown-Regulation, and Chemosensitization of Non-Hodgkin’s Lymphoma B Cells by Rituximab
Cancer research (2004) - Comments
pubmed: 15466208  doi: 10.1158/0008-5472.can-03-3500  issn: 0008-5472  issn: 1538-7445 

Ali R. Jazirehi, Mario I. Vega, Devasis Chatterjee, Lee Goodglick, Benjamin Bonavida